As neuronal NHE1 activation occurs early after ischemic injury (within 24 h) [41], we concluded that the delayed administration of either HOE642 or Rimeporide at 24 h post-stroke exerted no neuroprotective effects. This evidence concerns the gene SLC9A1 and Stroke.